We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · July 04, 2022

Tolerability and Treatment Outcomes of COVID-19 Monoclonal Antibodies Administered During Pregnancy

American Journal of Obstetrics & Gynecology

 

Additional Info

American Journal of Obstetrics & Gynecology
A real-world assessment of tolerability and treatment outcomes of COVID-19 monoclonal antibodies administered in pregnancy
Am J Obstet Gynecol 2022 May 01;226(5)743-745, MH Chang, K Cowman, Y Guo, H Bao, PS Bernstein, I Gendlina, P Nori

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading